Background: Albumin is the maximum plentiful circulating protein determined with inside the plasma. In oncology establishments, the commonly assessed parameter for the benefit of the patients like the liver function, renal function, nutritional status, and overall protein status and gastro intestinal assessment remains to be serum albumin. This study is a comparative evaluation of the results of serum albumin levels in oncology patients estimated by two different methodologies and thereby emphasizing the suitability and clinical applicability of the method to evaluate this acute phase reactant serum albumin.
Materials and Methods: In this analytical retrospective study, samples received in the laboratory of all Oncology patients (non specific to type of malignancy) of all age groups and gender was included in the study to estimate serum albumin by two different methods Bromocresol Green and Bromocresol purple. The results were compared for further evaluation.
Results: For a sample size of 200,it was observed that 169 samples (84%) shows albumin levels are lower by BCP than BCG method, 11 (6%) were higher and 20 (10% ) were equal. Among the 11 samples where albumin estimation was evidences high using the BCP method, 5 samples had values greater than 6 gm/dl.
Conclusion: This study helps in comparison of results of serum albumin by two different methods and determining an effective method to use.
Keywords: Albumin, BCG Bromocresol green, BCP Bromocresol purple
